Ionis Pharmaceuticals IONS Deferred Tax Liabilities
Deferred Tax Liabilities at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:DeferredTaxLiabilitiesOther.
The official record: Ionis Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's deferred tax liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's deferred tax liabilities?
- Ionis Pharmaceuticals (IONS) reported deferred tax liabilities of $7.15M in Q4 2025.
- What does deferred tax liabilities mean?
- Future tax payments resulting from timing differences between accounting and tax reporting.
- How do you interpret deferred tax liabilities?
- An increase indicates that the company has recognized income for tax purposes later than for financial reporting, or vice versa for expenses.
- How does deferred tax liabilities compare across companies?
- Standard liability for almost all corporations; levels depend on depreciation and amortization policies.